Septic Coagulopathy: Pathophysiology, Diagnosis, and Therapeutic Strategies
- 22 January 2024
- journal article
- review article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 26 (3) , 91-106
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational studyCritical Care, 2014
- A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsisCritical Care, 2013
- Recombinant Thrombomodulin Protects Mice against Histone-Induced Lethal ThromboembolismPLOS ONE, 2013
- Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort studyThrombosis Journal, 2013
- Autophagy Mediates the Delivery of Thrombogenic Tissue Factor to Neutrophil Extracellular Traps in Human SepsisPLOS ONE, 2012
- Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsisIntensive Care Medicine, 2011
- Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adultsCritical Care, 2010
- SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASEMediterranean Journal of Hematology and Infectious Diseases, 2010
- Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study)*Critical Care Medicine, 2009
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996